Creatd (OTCQB: CRTD) set the record date for its annual shareholder meeting on April 17, 2026, with a virtual meeting scheduled for May 21, 2026. Shareholders of record at the close of business on April 17 may vote electronically.
The company said it is preparing to file 2025 audited financials and to re-register with the SEC as part of steps toward uplisting after trading above $4.00 for 30 consecutive days. The company previously traded under the temporary symbol CRTDD following a reverse split and has returned to CRTD.
Creatd (OTCQB: CRTDD) sold its remaining 80% stake in Fly Flyte to NYSE American-listed Catheter Precision (VTAK) on March 10, 2026, receiving about $6,000,000 cash plus nearly $6,000,000 in VTAK convertible preferred stock. The transaction strengthens Creatd's balance sheet and leaves Creatd as a significant VTAK shareholder while supporting its national exchange listing strategy and continued collaboration on aviation and eVTOL initiatives.